Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAX8 | Q06710 | 3/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | MMP9 | P14780 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.35 |
| ▸ | PARP1 | P09874 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dacarbazine SCHEMBL28242658 | 1.00 | PAX8 (0.57) | PAX8LMNATSHRKDM4EALDH1A1 | |
| Dacarbazine SCHEMBL28292158 | 0.98 | PAX8 (0.56) | PAX8LMNATSHRKDM4EALDH1A1 | |
| Dacarbazine SCHEMBL12591753 | 0.98 | PAX8 (0.59) | PAX8LMNATSHRKDM4EALDH1A1 | |
| Dacarbazine SCHEMBL5560 | 0.98 | PAX8 (0.59) | PAX8LMNATSHRKDM4EALDH1A1 | |
| Dacarbazine SCHEMBL1586950 | 0.98 | PAX8 (0.59) | PAX8LMNATSHRKDM4EALDH1A1 | |
| Dacarbazine SCHEMBL6372 | 0.98 | PAX8 (0.59) | PAX8LMNATSHRKDM4EALDH1A1 | |
| Dacarbazine SCHEMBL29042921 | 0.97 | PAX8 (0.57) | PAX8LMNATSHRKDM4EALDH1A1 | |
| Dacarbazine SCHEMBL28074490 | 0.97 | PAX8 (0.57) | PAX8LMNATSHRKDM4EALDH1A1 | |
| Dacarbazine SCHEMBL28074492 | 0.97 | PAX8 (0.57) | PAX8LMNATSHRKDM4EALDH1A1 | |
| Dacarbazine SCHEMBL28090782 | 0.97 | PAX8 (0.57) | PAX8LMNATSHRKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108498796-A | A kind of novel PD-1 tumour immunities inhibitor and its process for preparing medicine | 河南天晟泰丰医药科技有限公司 | 2018-09-07 | — | — | CN | disclosed |
| US-20160206717-A1 | STIMULATION OF IMMUNITY TO ENDOTHELIAL CELLS, ENDOTHELIAL-LIKE CELLS, AND INTRATUMOR VASCULAR CHANNELS DERIVED FROM TUMOR TISSUE | BATU BIOLOG INC (US) | 2016-07-21 | — | — | US | disclosed |
| EP-1551388-A4 | COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER, COMPOSITIONS THEREOF AND METHODS THEREWITH | SIGNAL PHARM INC (US) | 2009-07-15 | — | — | EP | disclosed |
| EP-1996020-A2 | PURINE COMPOUNDS AND METHODS OF USE THEREOF | Inotek Pharmaceuticals Corporation (US) | 2008-12-03 | — | — | EP | disclosed |
| WO-2007111954-A2 | PURINE COMPOUNDS AND METHODS OF USE THEREOF | INOTEK PHAMACEUTICALS CORPORATION (US) | 2007-10-04 | — | — | WO | disclosed |
| EP-1802316-A2 | PURINE DERIVATIVES AND METHODS OF USE THEREOF | Inotek Pharmaceuticals Corporation (US) | 2007-07-04 | — | — | EP | disclosed |
| EP-1644323-A4 | HISTONE DEACETYLASE INHIBITORS AND METHODS OF USE THEREOF | UNIV GEORGETOWN (US) | 2007-06-20 | — | — | EP | disclosed |
| EP-1692128-A1 | INDAZOLE COMPOUNDS AND METHODS OF USE THEREOF AS PROTEIN KINASE INHIBITORS | Signal Pharmaceuticals LLC (US) | 2006-08-23 | — | — | EP | disclosed |
| EP-1390393-A4 | PENTAPEPTIDE COMPOUNDS AND USES RELATED THERETO | SEATTLE GENETICS INC (US) | 2006-05-24 | — | — | EP | disclosed |
| EP-1644323-A2 | HISTONE DEACETYLASE INHIBITORS AND METHODS OF USE THEREOF | GEORGETOWN UNIVERSITY (US) | 2006-04-12 | — | — | EP | disclosed |
| WO-2006034190-A2 | PURINE DERIVATIVES AND METHODS OF USE THEREOF | INOTEK PHARMACEUTICALS CORPORATION (US) | 2006-03-30 | — | — | WO | disclosed |
| EP-1551388-A2 | COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER, COMPOSITIONS THEREOF AND METHODS THEREWITH | Signal Pharmaceuticals, Inc. (US) | 2005-07-13 | — | — | EP | disclosed |
| WO-2005051942-A1 | INDAZOLE COMPOUNDS AND METHODS OF USE THEREOF AS PROTEIN KINASE INHIBITORS | SIGNAL PHARMACEUTICALS, LLC (US) | 2005-06-09 | — | — | WO | disclosed |
| WO-2005007091-A2 | HISTONE DEACETYLASE INHIBITORS AND METHODS OF USE THEREOF | GEORGETOWN UNIVERSITY (US) | 2005-01-27 | — | — | WO | disclosed |
| EP-1390393-A2 | PENTAPEPTIDE COMPOUNDS AND USES RELATED THERETO | Seattle Genetics, Inc. (US) | 2004-02-25 | — | — | EP | disclosed |
| WO-2003105774-A2 | COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER, COMPOSITIONS THEREOF AND METHODS THEREWITH | SIGNAL PHARMACEUTICALS, INC. (US) | 2003-12-24 | — | — | WO | disclosed |
| WO-2002088172-A2 | PENTAPEPTIDE COMPOUNDS AND USES RELATED THERETO | SEATTLE GENETICS, INC. (US) | 2002-11-07 | — | — | WO | disclosed |